Volume8, Issue0 (2025)

Cancer Drug Resistance

Search Submit

Cancer Drug Resistance

ISSN 2578-532X (Online)

[email protected]

Navigation

Sitemap

LinkedIn
Twitter
WeChat

Navigation

Sitemap

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Discover Content

Strategic Collaborators

Follow OAE

Privacy Cookies Terms of Service

Volume

Table of Contents (22 articles)

Strategies to combat cancer drug resistance: focus on copper metabolism and cuproptosis

The genetic architecture of bone metastases: unveiling the role of epigenetic and genetic modifications in drug resistance

Ivosidenib enhances cisplatin sensitivity in ovarian cancer by reducing cancer cell stemness

Tumor microenvironment-driven resistance to immunotherapy in non-small cell lung cancer: strategies for Cold-to-Hot tumor transformation

Unveiling MAGEA3: a novel predictive biomarker for bevacizumab resistance in colorectal cancer

Mechanisms of resistance to NAMPT inhibitors in cancer

Circular RNAs modulate cancer drug resistance: advances and challenges

Exosomal miR-92b-5p regulates N4BP1 to enhance PTEN mono-ubiquitination in doxorubicin-resistant AML

Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways

Unraveling BRAF alterations: molecular insights to circumvent therapeutic resistance across cancer types

The epigenetic mechanisms involved in the treatment resistance of glioblastoma

Antibody-drug conjugates in breast cancer treatment: resistance mechanisms and the role of therapeutic sequencing

Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma

Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches

Exploring YAP1-related TIME in SCLC: implications for survival and treatment response to immuno-chemotherapy

Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance

Histone deacetylases in the regulation of cell death and survival mechanisms in resistant BRAF-mutant cancers

Optimizing therapeutic approaches for HR+/HER2- advanced breast cancer: clinical perspectives on biomarkers and treatment strategies post-CDK4/6 inhibitor progression

Regulatory role of non-coding RNAs in 5-Fluorouracil resistance in gastrointestinal cancers

Integrative multi-omics analysis for identifying novel therapeutic targets and predicting immunotherapy efficacy in lung adenocarcinoma

Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment

Ferroptosis-related signaling pathways in cancer drug resistance

Actions for 0 selected articles

Committee on Publication Ethics

Portico

Committee on Publication Ethics

Portico